Growing GLP-1 Costs Raise Importance of Pharmacy Strategy for Staffing Firms

As employers face rising healthcare costs and difficult decisions surrounding GLP-1 medications heading into 2027, businesses must look beyond traditional benefit models to protect both their budgets and their workforce. As Paul Pruitt notes, “Higher premiums, greater cost sharing, and another version of the same pharmacy model may shift the expense but will not solve it.”

To gain predictable control over pharmacy spend without simply transferring unsustainable costs to employees, executives need to evaluate alternative access pathways and bring finance and HR together.